Top Markets
Coin of the day
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd

SynCore Biotechnology Co.,Ltd

4192
Xếp hạng trong cổ phiếu #29318
SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the... SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the development and commercialization of biotechnology services, alongside offering expertise in food advisory and medicine inspection. The company's robust pipeline includes several promising drug candidates. Among its novel chemical entities (NCEs), SB01 is an injectable anti-cancer compound currently undergoing Phase II clinical trials for head and neck cancer. Another anti-cancer NCE, SB02, is in preclinical development, targeting stomach cancer. Beyond novel compounds, SynCore also markets established pharmaceutical solutions. This includes SB03-Veregen, an ointment prescribed for external genital and perianal warts. Its portfolio further extends to SB04, a conventional medication for age-related macular degeneration, presently in Phase II clinical studies. Additionally, SynCore is advancing SB05-EndoTAG, an established drug undergoing Phase III clinical trials for the treatment of both pancreatic cancer and triple-negative breast cancer. In a related venture, the company distributes epiCam brand cameras, which are designed for recording the progression of ophthalmic diseases. SynCore maintains strategic collaborations with notable entities such as Medigene AG, MacuCLEAR Inc., Sinphar Pharmaceutical Co., Ltd., and The National Health Research Institutes. Founded in 2008, SynCore Biotechnology Co.,Ltd is headquartered in Yilan City, Taiwan, and operates as a subsidiary of Sinphar Pharmaceutical Co., Ltd.
Giá cổ phiếu
$0.62008105
Đồng bộ lần cuối: 2026-08-18
Vốn hóa thị trường
$21.81M
Thay đổi (1 ngày)
0.26%
Thay đổi (1 năm)
-31.95%
Quốc gia
TW
Giao dịch SynCore Biotechnology Co.,Ltd (4192)

Danh mục

Lịch sử giá cổ phiếu của SynCore Biotechnology Co.,Ltd (4192)
Giá đóng cửa cao nhất: $0.61 vào 2026-08-01

Giá đóng cửa thấp nhất: $13.69 vào 2013-08-01
Lịch sử giá cổ phiếu của SynCore Biotechnology Co.,Ltd từ 2013 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -9.35%
2025 -24.35%
2024 -10.36%
2023 -62.29%
2022 -26.18%
2021 -28.63%
2020 65.85%
2019 23.95%
2018 -14.52%
2017 1.90%
2016 -35.02%
2015 -31.09%
2014 -30.70%
2013 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$551.16 41.05%
US
$163.88 487.17%
US
$1.03K 57.08%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH